Atopic dermatitis (AD) represents the most common skin disease characterized by
heterogeneous endophenotypes and a high disease burden. In Europe, six new systemic …

In severe cases of atopic dermatitis (AD) systemic treatment is indicated. So far, cyclosporine
and systemic glucocorticosteroids represented the only systemic treatment options approved …

Introduction: For many years, oral immunosuppressive drugs such as cyclosporine A,
azathioprine, mycophenolic acid, and methotrexate were the only treatment options, in …

Background Atopic dermatitis is a common, chronically recurring inflammatory skin disease.
It gives rise to a high disease burden and is of major importance in social medicine. Methods …

Atopic dermatitis (AD) is a chronic, lifelong, relapsing condition. The wide spectrum of the
possible clinical presentations, depending on patient's age, age of onset of disease …

The latest findings regarding AD pathogenesis point to an impaired function of the epidermal
barrier, changed immune response, colonization of the skin by microorganisms, and certain …

Introduction: Atopic dermatitis (AD) is a heterogeneous disease. Recent advancements in
understanding AD pathogenesis resulted in the exponential expansion of its therapeutic …

Background Dupilumab (an anti-interleukin-4-receptor-α monoclonal antibody) blocks
signalling of interleukin 4 and interleukin 13, type 2/Th2 cytokines implicated in numerous …

Atopic dermatitis (AD) is an itchy chronic relapsing inflammatory skin condition mostly
affecting children than adults. Eczematous conditions are common worldwide with increase …

Atopic eczema (AE) is a chronic inflammatory disease hallmarked by intense pruritus and
eczematous lesions. It depicts one of the most common skin diseases affecting a major part …